From Clinical Credibility to Barrier Care Brand
Prequel is a dermatologist-founded skincare brand built around barrier care products and a viral glycerin cleanser, translating clinical experience into accessible routines that aim to prevent skin problems before a specialist visit is needed. This origin story matters because it explains why Prequel’s growth looks different from trend-first brands. Founder Dr Samantha Ellis, a board-certified dermatologist, spent years treating acne, eczema and sensitive skin, then realised the market was split between basic drugstore formulas, prescription treatments and pricey luxury lines with little middle ground. Her answer was barrier-focused, dermatology-informed skincare at everyday prices, designed to give skin “what it actually needs before a visit to a dermatologist becomes necessary.” In a crowded field of dermatologist-founded skincare brands, Prequel’s point of view is less about chasing the newest active and more about making clinical thinking available in the bathroom cabinet.
Gleanser: Viral Demand With a Different Kind of Hype
Prequel’s breakout moment came not from a celebrity endorsement, but from a humble cleanser: Gleanser. The gel formula carries an unusually high 50% glycerin content, a difficult cosmetic chemistry task given how sticky and unstable high-glycerin systems can be. That technical choice signals the brand’s priorities—comfort for dry, sensitive and compromised skin over flashy claims. Gleanser quickly turned into the Prequel skincare brand’s defining hero, with more than one million bottles sold within a few years. Unlike many viral launches, momentum here came from Ellis’ existing credibility and #SkinTok word-of-mouth rather than aggressive paid campaigns. According to one report, Prequel’s success “suggests there is still room for brands that prioritise education, thoughtful formulation, and consistency over constant reinvention.” In other words, the viral response validated that consumers were ready to reward barrier care products grounded in clinical thinking, not just trend cycles.
Retail Validation: Target Shelves and Space NK Counters
Prequel’s shift from online favourite to mainstream retail player is the clearest proof that clinical credibility plus viral demand can power skincare brand scaling retail. After launching direct-to-consumer in 2023, the brand moved into one of the largest mass retailers when it landed on shelves at Target in August 2024. That placement dramatically widened reach, and the brand reports sales at Target have grown by more than 150% year on year, a sharp signal of appetite for dermatologist-developed skincare at attainable prices. Products remain relatively affordable, starting at USD 14 (approx. RM64) in the US and £19 in the UK. At the same time, Prequel established US distribution through Target, Amazon and its own website, building a multichannel presence rather than relying on a single retailer. The next step up in retail validation came when the UK became its first international market through an exclusive Space NK partnership, described as the retailer’s biggest skincare launch of the year.
Strategic Leadership for International Ambitions
Prequel’s recent leadership changes make clear that the brand is no longer in a scrappy start-up phase—it is organising for scale. After entering its first international market through an exclusive UK launch with Space NK on 14 July, the company appointed former Huda Beauty chief Nathalie Kristo as CEO and Toral Patel as CMO to oversee marketing and e-commerce. These hires are not cosmetic. Kristo brings more than 25 years in beauty, including senior roles at L’Oréal and a track record transforming NYX Professional Makeup into a global business and supporting international expansion at Huda Beauty and Kayali. Patel offers more than 15 years across prestige and mass, most recently heading marketing and e-commerce at Kopari Beauty and previously working at The Estée Lauder Companies and L’Oréal. Together, they are tasked with expanding Prequel’s reach while protecting its clinical positioning and consumer trust—explicitly framing scale as something that must serve, not dilute, the underlying dermatologic authority.
What Prequel’s Trajectory Signals for Future Skincare Brands
Prequel shows how dermatologist-founded skincare brands can grow without sacrificing substance. Ellis built the brand’s “Basic+” philosophy—elevated everyday staples with barrier support—before adding moisturisers, hypochlorous sprays and bodycare, all kept within a clinically informed, fragrance-free, barrier-first frame. The Center, the Los Angeles beauty incubator behind the launch, helped with formulation, branding, manufacturing and retail strategy, allowing Ellis to stay focused on effective skincare while a seasoned team built commercial infrastructure. The result is a company now backed by mass retail presence, international distribution and leadership experienced in global expansion. Ordinary users feel this evolution mainly through access: dermatology-informed products they can rely on daily to support the skin barrier and long-term skin health, at prices that do not demand a luxury budget. As Kristo put it, her focus is to “nurture what makes Prequel special while building the organisation to carry it into its next chapter of growth.” That next chapter will test whether barrier care and education can stay at the centre while scale accelerates.
